← Insider buys
SRPT

Sarepta Therapeutics, Inc. · Healthcare

Director Hans Lennart Rudolf Wigzell sold $937K of Sarepta Therapeutics, Inc.

Sold$936,714
$140.50Price
6,667Shares
−40%Stake

What SRPT did after the filing

Prices for SRPT after this filing aren't in yet.

Traded Thu, Nov 1. Filed Fri, Nov 2, 2:01 PM ET, during the session. Not investment advice.